Where Are Estrogen Receptors Located?

Estrogen receptors are found in nearly every tissue in the human body, not just the reproductive organs most people associate with the hormone. The two classic nuclear receptors, commonly called ERα and ERβ, show up in the brain, bones, heart, lungs, gut, skin, liver, fat, immune cells, and more. A third receptor, GPER, sits mainly in cell membranes and adds another layer of estrogen signaling. Even within a single cell, estrogen receptors can occupy different compartments, from the nucleus to the cell surface, and this positioning changes what they do. The full map of estrogen receptor distribution helps explain why estrogen influences so many aspects of health beyond fertility.

Inside the Cell, Not Just in the Nucleus

Estrogen receptors were originally understood as nuclear transcription factors, proteins that sit in the nucleus and switch genes on or off when estrogen binds to them. That picture is accurate but incomplete. A fraction of ERα also localizes near the plasma membrane, where it triggers rapid signaling effects that do not require changes in gene expression. These fast, membrane-initiated signals have been well documented in endothelial cells, the cells lining blood vessels.¹ Research in breast cancer cells has shown that membrane-associated ERα clusters in specialized lipid-rich regions of the membrane and colocalizes with scaffolding proteins called caveolins, which help organize the receptor’s signaling at the cell surface.²

ERα is not stuck in one spot. It continuously shuttles between the nucleus and the cytoplasm, and this movement matters for how strongly the receptor drives gene activity.³ Meanwhile, ERβ tends to appear more heavily in the cytoplasm and in mitochondria. In uterine tissue, a substantial portion of estrogen binding has been detected in the mitochondrial fraction, where the hormone binds with high affinity. This mitochondrial pool was associated mainly with ERβ.⁴ These findings mean that estrogen does not just flip genes in the nucleus; it can also influence energy production and cell metabolism through receptors stationed inside mitochondria and at the cell surface.

GPER, the Membrane Receptor That Complicates the Picture

Beyond ERα and ERβ, a structurally distinct receptor called GPER (sometimes referred to as GPR30) responds to estrogen from the cell membrane. Unlike the classic receptors, GPER is a transmembrane protein that signals through a completely different molecular pathway. It plays roles in the reproductive, nervous, endocrine, immune, and cardiovascular systems, and it is being studied as a potential therapeutic target in cancer.⁵

There has been some controversy about where GPER actually sits. In breast cancer cells, the bulk of GPER is found inside the cell rather than on the surface, with only minor amounts detectable at the plasma membrane.⁶ Whether GPER’s main job happens at the surface or internally is still debated, but either way, it gives cells an additional mechanism for responding to estrogen that works on a faster timescale than the classic nuclear pathway.

The Female Reproductive Tract

The uterus, ovaries, and related structures are the most obvious estrogen-receptor hotspots, but the two receptor subtypes are not spread evenly. In the uterus, oviduct, and cervix, ERα dominates. Its levels fluctuate throughout the menstrual cycle, rising and falling in the tissue’s stroma and epithelium at different phases. In the ovaries, the situation reverses: ERβ is the main receptor, particularly in the granulosa cells of developing follicles. ERα is present in ovarian stromal cells but at lower levels.⁷ This division of labor means that the uterus and the ovary respond to estrogen through different receptor-driven programs, which helps explain why these organs can behave so differently even though they are bathed in the same hormones.

Estrogen Receptors in Males

One of the most persistent misconceptions about estrogen is that it is a “female hormone.” Men produce estrogen too, converted from testosterone by an enzyme called aromatase, and estrogen receptors are scattered throughout male tissues. Both ERα and ERβ, along with GPER, are expressed in male reproductive and nonreproductive organs.⁸

In the male reproductive tract, estrogen receptors are especially concentrated in the efferent ductules, the tiny tubes connecting the testis to the epididymis. There, ERα regulates proteins involved in fluid reabsorption, and when this signaling is disrupted, sperm can become abnormal because the fluid environment goes awry.⁹ Interestingly, ERα has been reported absent from the testis itself in a few species, including humans, though ERβ is present there.⁹

The prostate also carries estrogen receptors. In studies of canine tissue, receptor staining was concentrated in the prostatic stroma and ductal epithelium, with higher intensity near the urethra than in the outer regions. The urethra itself contained a higher concentration of estrogen receptors than the prostate overall.¹⁰ These receptor locations map neatly onto the areas of the prostate that change most in response to estrogen exposure, suggesting the receptors are biologically active rather than just sitting there.

The Brain

Estrogen receptors in the brain have attracted a lot of research attention, partly because of their ties to cognition, mood, and neuroprotection. Membrane-associated estrogen receptors have been identified in the prefrontal cortex, dorsal striatum, nucleus accumbens, and hippocampus, all regions involved in learning, memory, and reward processing.¹¹ Their presence in these areas helps explain why cognitive performance can shift during the menstrual cycle, pregnancy, and menopause, times when circulating estrogen levels change substantially.

Brain expression of ERα is not constant across the lifespan. In the rodent cerebral cortex, ERα expression is high early in postnatal life and then drops sharply as the animal approaches puberty.¹² This pattern suggests that estrogen signaling in the developing brain serves organizational functions, shaping neural circuits during critical windows before stepping back later.

Heart and Blood Vessels

Both ERα and ERβ are present in endothelial cells, where their localization has been carefully studied. In vascular smooth muscle cells and heart muscle cells, the receptors are also present but their precise intracellular positioning has been less thoroughly mapped.¹³ What researchers do know is that estrogen signaling in blood vessels promotes vasodilation, reduces inflammation, and influences cholesterol handling, which is part of the reason premenopausal women tend to have lower rates of cardiovascular disease than age-matched men. The gap narrows after menopause when estrogen levels fall, and the estrogen receptors in vessel walls are no longer activated to the same degree.

Bones, Muscles, and Metabolism

Estrogen is one of the key hormones keeping bones strong. Both ERα and ERβ are present in the main bone cell types: osteoblasts (which build bone), osteocytes (which maintain it), and osteoclasts (which break it down). Estrogen signaling suppresses excessive bone resorption, and when estrogen drops during menopause, that brake is released, leading to accelerated bone loss.¹⁴

Beyond bone, estrogen receptors show up in tissues you might associate more with metabolism. ERα and ERβ are found in skeletal muscle, adipose tissue, the pancreas, and the liver, giving estrogen influence over glucose handling, fat storage, and energy balance.¹⁵ This widespread metabolic reach is part of why menopause often comes with shifts in body composition, insulin sensitivity, and cholesterol levels, the receptor network that was helping regulate all those processes is suddenly receiving much less signal.

The Immune System

Estrogen receptors regulate both the innate and adaptive arms of the immune system, as well as immune cell development. Their effects on innate immune signaling and on the development of myeloid cells (the white blood cells that serve as first responders to infection) are profoundly dose- and context-dependent.¹⁶ This helps explain a well-known clinical pattern: women generally mount stronger immune responses than men, which is protective against infections but also makes autoimmune diseases far more common in women. The estrogen receptors on immune cells are a major reason for this sex-based difference in immune behavior.

The Gut, Lungs, and Skin

ERβ is the dominant estrogen receptor in the colon, and it appears to act as a brake on cell growth there. When researchers knocked out ERβ in mice, the colonic epithelium showed more proliferating cells and faster cell migration toward the gut surface compared to normal mice.¹⁷ That finding has implications for colorectal cancer risk: if ERβ normally restrains cell division in the colon, losing its function could contribute to uncontrolled growth.

In the lungs, estrogen receptors are widely expressed across airway epithelium, smooth muscle, fibroblasts, the lung’s blood vessel lining, and immune cells resident in the lung.¹⁸ Both ERα and ERβ transcripts are found in normal lung tissue, with ERβ present in every sample tested in one study. ERα appeared in about 83% of normal lung tissue samples, and the levels were similar in men and women.¹⁹ In severe COPD, ERα levels drop in bronchial epithelial cells and lung immune cells, while ERβ actually increases in the alveolar region, suggesting the two receptors respond differently to chronic lung disease.²⁰

The skin is another site most people would not associate with estrogen. Estrogen receptors have been found in the dermal papilla, the cluster of cells at the base of each hair follicle that controls hair growth. The receptor’s expression there is hair-cycle dependent, peaking when the follicle is in its resting phase.²¹ This connection between estrogen and hair cycling may be part of the reason hair texture, thickness, and growth patterns shift during pregnancy and menopause.

How Receptor Distribution Changes with Age

The map of estrogen receptors is not fixed. It changes over the course of development and aging. In sheep fetuses, ERα first becomes detectable in dorsal root ganglia neurons at about day 90 of gestation, while ERβ does not appear until day 120, and even then only a small fraction of neurons (roughly 8%) express it at birth.²² This staggered appearance means that different developmental windows are governed by different receptor subtypes.

At the other end of life, receptor levels decline. In human female skeletal muscle, ERα protein expression was about 48% lower in women aged 55 and older compared to women under 30. GPER expression was roughly 22% lower across all older age groups. ERβ showed a dip in midlife (ages 45 to 59) but rebounded in the oldest group.²³ These age-related shifts in receptor density compound the problem of falling estrogen levels after menopause: not only is there less hormone circulating, but there are fewer receptors available to respond to whatever estrogen remains.

Estrogen Receptors and Cancer

In cancer biology, estrogen receptor status is one of the most clinically important markers. About 70% of breast cancers show high expression and activity of ERα, and the receptor’s ability to drive genes associated with cell proliferation and survival makes it a central player in tumor growth.³ Drugs like tamoxifen and the aromatase inhibitors work by interfering with estrogen receptor signaling, either blocking the receptor directly or starving it of its ligand.

Estrogen receptors are also relevant to prostate cancer. Both ERα and ERβ have been shown to have disrupted expression and function in prostate malignancies, where they exert both genomic and non-genomic actions as transcription factors.²⁴ The presence of estrogen receptors in normal lung tissue at high rates has also raised the question of whether they play a role in lung carcinogenesis, a question that gains urgency given that lung cancer rates in never-smoking women have been rising in some populations.¹⁹

Endocrine Disruptors and Receptor Interference

Because estrogen receptors are so widespread, chemicals that mimic or block estrogen can cause problems in unexpected places. Endocrine-disrupting chemicals, found in plastics, pesticides, and various industrial products, can activate membrane estrogen receptors directly. They can also alter the proportion of receptors that reach the cell membrane, potentially changing the balance between fast membrane signaling and slower nuclear gene regulation.²⁵ This is one reason why endocrine disruptors are so hard to study and regulate: the same chemical might have one effect in a tissue where ERα dominates and a different effect in a tissue where ERβ or GPER is the main responder.

How Receptor Patterns Compare Across Species

Estrogen receptors are ancient. Their roles in non-reproductive tissues such as the cardiovascular system, kidney, bone, and brain appear to have emerged early in vertebrate evolution, well before mammals existed.²⁶ In fish, the two receptor subtypes already show distinct tissue distributions: in the sea bream, ERα appears mainly in the testis, liver, and heart, while ERβ is more broadly distributed, showing up in the ovary, testis, liver, intestine, and kidney.²⁷ The fact that ERβ is the more ubiquitous subtype in fish, just as it tends to have broader expression in mammals, suggests that this division of labor between the two receptors is something evolution settled on hundreds of millions of years ago and has preserved since.